首页> 外文期刊>Systems biomedicine. >sbv IMPROVER Diagnostic Signature Challenge Scoring strategies
【24h】

sbv IMPROVER Diagnostic Signature Challenge Scoring strategies

机译:sbv IMPROVER诊断签名挑战评分策略

获取原文
       

摘要

Evaluating the performance of computational methods to analyze high throughput data are an integral component of model development and critical to progress in computational biology. In collaborative-competitions, model performance evaluation is crucial to determine the best performing submission. Here we present the scoring methodology used to assess 54 submissions to the IMPROVER Diagnostic Signature Challenge. Participants were tasked with classifying patients’ disease phenotype based on gene expression data in four disease areas: Psoriasis, Chronic Obstructive Pulmonary Disease, Lung Cancer, and Multiple Sclerosis. We discuss the criteria underlying the choice of the three scoring metrics we chose to assess the performance of the submitted models. The statistical significance of the difference in performance between individual submissions and classification tasks varied according to these different metrics. Accordingly, we consider an aggregation of these three assessment methods and present the approaches considered for aggregating the ranking and ultimately determining the final overall best performer.
机译:评估分析高通量数据的计算方法的性能是模型开发不可或缺的组成部分,对于计算生物学的进展至关重要。在协作竞赛中,模型性能评估对于确定表现最佳的提交至关重要。在这里,我们介绍了一种评分方法,用于评估IMPROVER诊断签名挑战赛的54项呈件。参与者要根据四个疾病领域的基因表达数据对患者的疾病表型进行分类:牛皮癣,慢性阻塞性肺疾病,肺癌和多发性硬化症。我们讨论了选择三个评分指标所依据的标准,我们选择了这三个评分指标来评估所提交模型的性能。个体提交和分类任务之间的性能差异的统计显着性根据这些不同的指标而有所不同。因此,我们考虑了这三种评估方法的汇总,并提出了用于汇总排名并最终确定最终总体最佳绩效的方法。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号